Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy

Affiliations

• ¹ Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. Jennifer.Mitchell@ucsf.edu.
• ² Department of Psychiatry & Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. Jennifer.Mitchell@ucsf.edu.
• ³ San Francisco VA Medical Center, San Francisco, CA, USA. Jennifer.Mitchell@ucsf.edu.
• ⁴ Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
• ⁵ MAPS Public Benefit Corporation (MAPS PBC), San Jose, CA, USA.
• ⁶ Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.